Sumitomo Pharma Co Ltd

TSE:4506 (Japan)  
円 568.00 (-0.53%) Dec 24
At Loss
P/B:
1.98
Market Cap:
円 226.85B ($ 1.44B)
Enterprise V:
円 500.32B ($ 3.18B)
Volume:
1.54M
Avg Vol (2M):
3.19M
Warning! GuruFocus detected 6 Severe warning signs with 4506. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
1.54M
Market Cap 円:
226.85B
Market Cap $:
1.44B
At Loss
Avg Vol (2M):
3.19M
Enterprise Value 円:
500.32B
Enterprise Value $:
3.18B
PB Ratio:
1.98
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Sumitomo Pharma Co Ltd
NAICS : 325412
ISIN : JP3495000006
https://www.sumitomo-pharma.com
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Compare
Compare
TSE:4887TSE:4516TSE:4530TSE:4521TSE:4547TSE:4553TSE:4551TSE:4534TSE:4540TSE:4559ZTSXTER:MRKNSE:SUNPHARMALSE:HLNTSE:4502XSWX:GALDXTAE:TEVANSE:DIVISLABXSWX:SDZVTRS
Traded in other countries / regions
4506.JapanDNPUF.USADPM.Germany
IPO Date
1949-05-16
Description
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Financial Strength

1/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.14
Debt-to-Equity 3.41
Debt-to-EBITDA -1.76
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.71
Distress
Grey
Safe
Beneish M-Score -4.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

4/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -15.2
3-Year Book Growth Rate -35.5
Future 3-5Y Total Revenue Growth Rate 4.76

Momentum Rank

1/10
Name Current Vs Industry Vs History
5-Day RSI 32.86
9-Day RSI 41
14-Day RSI 43.98
6-1 Month Momentum % 72.03
12-1 Month Momentum % 32.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.64
Quick Ratio 0.42
Cash Ratio 0.24
Days Inventory 285.35
Days Sales Outstanding 89.33
Days Payable 154.34

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -31.61

Profitability Rank

5/10
Name Current Vs Industry Vs History
Gross Margin % 59.56
Operating Margin % -80.7
Net Margin % -81.55
FCF Margin % -22.88
ROE % -108.97
ROA % -28.54
ROIC % -23.99
ROC (Joel Greenblatt) % -383.21
ROCE % -47.99
Years of Profitability over Past 10-Year 8

GF Value Rank

6/10
Name Current Vs Industry Vs History
Forward PE Ratio 18.58
PS Ratio 0.66
PB Ratio 1.98
EV-to-EBIT -1.97
EV-to-Forward-EBIT -8.05
EV-to-EBITDA -2.25
EV-to-Forward-EBITDA 16.99
EV-to-Revenue 1.46
EV-to-Forward-Revenue 1.27
EV-to-FCF -6.38
Price-to-Projected-FCF 7.19
Price-to-Median-PS-Value 0.47
Earnings Yield (Greenblatt) % -50.87
FCF Yield % -34.74
Forward Rate of Return (Yacktman) % 17.97

Financials

TSE:4506's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sumitomo Pharma Co Ltd Executives

Details

GF Value: 円512.16

TSE:4506

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 342,665
EPS (TTM) (円) -703.405
Beta -0.31
Volatility % 78.97
14-Day RSI 43.98
14-Day ATR (円) 21.562569
20-Day SMA (円) 581.2
12-1 Month Momentum % 32.97
52-Week Range (円) 279 - 692
Shares Outstanding (Mil) 397.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sumitomo Pharma Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Sumitomo Pharma Co Ltd Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Sumitomo Pharma Co Ltd Frequently Asked Questions

What is Sumitomo Pharma Co Ltd(TSE:4506)'s stock price today?
The current price of TSE:4506 is 円568.00. The 52 week high of TSE:4506 is 円692.00 and 52 week low is 円279.00.
When is next earnings date of Sumitomo Pharma Co Ltd(TSE:4506)?
The next earnings date of Sumitomo Pharma Co Ltd(TSE:4506) is .
Does Sumitomo Pharma Co Ltd(TSE:4506) pay dividends? If so, how much?
Sumitomo Pharma Co Ltd(TSE:4506) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.